» Articles » PMID: 38172903

Association of Long-term Triglyceride-glucose Index Patterns with the Incidence of Chronic Kidney Disease Among Non-diabetic Population: Evidence from a Functional Community Cohort

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance and previous studies have confirmed the association of TyG index with incident chronic kidney disease (CKD). However, the impact of longitudinal patterns of TyG index on CKD risk among non-diabetic population is still unknown. Therefore, this study aimed to investigate the association of longitudinal patterns of TyG index with incident CKD among non-diabetic population.

Methods: A total of 5484 non-diabetic participants who underwent one health examination per year from 2015 to 2017 were included in this prospective study. TyG index variability and cumulative TyG index were calculated to assess the longitudinal patterns of TyG index. Cox proportional hazard models were performed to estimate the association of TyG index variability or cumulative TyG index with incident CKD.

Results: During a median of 3.82 years follow-up, 879 participants developed CKD. Compared with participants in the lowest quartile, the hazard ratio (HR) and 95% confidence interval (CI) of incident CKD were 1.772 (95% CI: 1.453, 2.162) for the highest TyG index variability quartile and 2.091 (95% CI: 1.646, 2.655) for the highest cumulative TyG index quartile in the fully adjusted models. The best discrimination and reclassification improvement were observed after adding baseline TyG, TyG index variability and cumulative TyG index to the clinical risk model for CKD.

Conclusions: Both TyG index variability and cumulative TyG index can independently predict incident CKD among non-diabetic population. Monitoring longitudinal patterns of TyG index may assist with prediction and prevention of incident CKD.

Citing Articles

The prognostic association of triglyceride-glucose index and its derived indicators with stable coronary artery disease patients undergoing percutaneous coronary intervention.

Shan Y, Lin M, Gu F, Li D, Zhu Q, Chen Z Front Endocrinol (Lausanne). 2025; 16:1465376.

PMID: 39911921 PMC: 11794097. DOI: 10.3389/fendo.2025.1465376.


Association between the cumulative estimated glucose disposal rate and incident cardiovascular disease in individuals over the age of 50 years and without diabetes: data from two large cohorts in China and the United States.

Zhang J, Sun Z, Li Y, Yang Y, Liu W, Huang M Cardiovasc Diabetol. 2025; 24(1):51.

PMID: 39891229 PMC: 11786493. DOI: 10.1186/s12933-025-02575-1.


Association of the triglyceride glucose index with acute renal failure in diabetes mellitus: a cross-sectional study based on participants from the MIMIC-iv database.

Zhuang Z, Lu H, Zhou Y, Ni Q Acta Diabetol. 2024; .

PMID: 39556222 DOI: 10.1007/s00592-024-02412-z.


Associations of physiologic subtypes based on HOMA2 indices of β-cell function and insulin sensitivity with the risk of kidney function decline, cardiovascular disease, and all-cause mortality from the 4C study.

Luo P, Li D, Guo Y, Meng X, Kan R, Pan L Cardiovasc Diabetol. 2024; 23(1):401.

PMID: 39511523 PMC: 11546320. DOI: 10.1186/s12933-024-02496-5.


The association between index-year, average, and variability of the triglyceride-glucose index with health outcomes: more than a decade of follow-up in Tehran lipid and glucose study.

Molavizadeh D, Cheraghloo N, Tohidi M, Azizi F, Hadaegh F Cardiovasc Diabetol. 2024; 23(1):321.

PMID: 39217401 PMC: 11365227. DOI: 10.1186/s12933-024-02387-9.


References
1.
de Boer I, Mehrotra R . Insulin resistance in chronic kidney disease: a step closer to effective evaluation and treatment. Kidney Int. 2014; 86(2):243-5. PMC: 4119606. DOI: 10.1038/ki.2014.123. View

2.
Sim R, Chong C, Loganadan N, Adam N, Hussein Z, Lee S . Comparison of a chronic kidney disease predictive model for type 2 diabetes mellitus in Malaysia using Cox regression versus machine learning approach. Clin Kidney J. 2023; 16(3):549-559. PMC: 9972828. DOI: 10.1093/ckj/sfac252. View

3.
Qi S, Xu Y, Zeng K, Li Y, Ma J . Incidence and Factors Associated with Hyperglycemia in Patients with First Hospitalization for Major Depression Disorder: A Large Cross-Sectional Sample. Neuropsychiatr Dis Treat. 2023; 19:1809-1818. PMC: 10455853. DOI: 10.2147/NDT.S421984. View

4.
Schrauben S, Jepson C, Hsu J, Wilson F, Zhang X, Lash J . Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study. BMC Nephrol. 2019; 20(1):60. PMC: 6383235. DOI: 10.1186/s12882-019-1220-6. View

5.
Cersosimo E, DeFronzo R . Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006; 22(6):423-36. DOI: 10.1002/dmrr.634. View